We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Echocardiography Service Automatically Identifies Coronary Artery Disease

By MedImaging International staff writers
Posted on 21 Jan 2021
Print article
Image: The EchoGo Pro clinical workflows for CAD analysis (Photo courtesy of Ultromics)
Image: The EchoGo Pro clinical workflows for CAD analysis (Photo courtesy of Ultromics)
An artificial intelligence (AI) powered, outcomes-driven, decision support tool improves the diagnostic accuracy of clinicians for coronary artery disease (CAD).

The Ultromics (Oxford, United Kingdom) EchoGo Pro is a fully automated solution for echocardiography and strain analysis. The cloud-based Software-as-a-Service (SaaS) platform uses AI to power the diagnostic pathway, providing near-instant reports without any need for physical software on site. EchoGo Pro complements EchoGo Core, a software application that measures standard cardiac parameters, including ejection fraction (EF), global longitudinal dtrain (GLS), and left ventricular (LV) volume, and also analyzes echocardiogram (ECG) cardiac parameters.

For Pro, the anonymized echocardiogram dataset is transferred and processed through the application’s workflow, and an auto-contouring algorithm places points around the LV that sufficiently capture the LV shape; these contours are then used for calculating geometric parameters. By automating ECG analysis as part of the cloud service, a complete accurate analysis can be delivered within minutes, and with zero variability, in a zero-click workflow, aiding identification of CAD. EchoGo Pro and EchoGo Core will be offered together in the EchoGo suite.

“Heart disease is the biggest killer globally, and this number is increasing daily. COVID-19 has placed an even greater pressure on cardiac care and looks likely to have lasting implications in terms of its impact on the heart,” said Ross Upton, MD, founder and CEO of Ultromics. “The healthcare industry needs to quickly pivot towards AI powered automation to reduce the time to diagnosis and improve patient care. We are making the EchoGo suite as complete and automated as possible to help clinicians rapidly assess disease and provide early, appropriate intervention.”

Cardiac ultrasound, or echocardiography, is a noninvasive diagnostic modality that can provide detailed hemodynamic information rapidly at the patient bedside. It was first adopted for diagnostic purposes in the 1960s as an inexpensive way to expedite diagnosis and management of imminently life-threatening cardiac disease, including pericardial tamponade, acute coronary syndrome (ACS), cardiomyopathy, pulmonary embolism (PE), and aortic dissection. Cardiac ultrasound can also differentiate shock states and guide resuscitative measures.

Related Links:
Ultromics

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
DR Flat Panel Detector
1500L
New
Color Doppler Ultrasound System
DRE Crystal 4PX
Laptop Ultrasound Scanner
PL-3018

Print article

Channels

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.